Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 103 Records) |
Query Trace: Neoplasms and SRD5A2[original query] |
---|
Relationship of early-onset baldness to prostate cancer in African-American men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Apr 22 (4): 589-96. Zeigler-Johnson Charnita, Morales Knashawn H, Spangler Elaine, Chang Bao-Li, Rebbeck Timothy |
Importance of 5a-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Feb 20 (3): 576-84. Lévesque Éric, Laverdière Isabelle, Lacombe Louis, Caron Patrick, Rouleau Mélanie, Turcotte Véronique, Têtu Bernard, Fradet Yves, Guillemette Chant |
Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones. Human reproduction (Oxford, England) 2014 Dec 29 (12): 2844-51. Aschim E L, Oldenburg J, Kristiansen W, Giwercman A, Witczak O, Fosså S D, Haugen T |
Polymorphism of the SRD5A2 gene and the risk of prostate cancer. Molecular medicine reports 2014 Dec 10 (6): 3151-6. Dušenka Róbert, Tomaškin Roman, Kliment Ján, Dobrota Dušan, Dušenková Svetlana, Vil?ková Marta, Sivo?ová Monika Kme?'o |
Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis. Genetics and molecular research : GMR 2015 14 (3): 9004-12. Zhang D, Li Q, Qu H-C, Yu T, Liu Y |
Genetic polymorphism in sex hormone metabolism and prostate cancer risk. Genetics and molecular research : GMR 2015 14 (3): 7326-34. Ersekerci E, Sofikerim M, Taheri S, Demirtas A, Halis |
Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study. Urologic oncology 2015 Jul 33 (7): 331.e1-7. Henríquez-Hernández Luis Alberto, Valenciano Almudena, Foro-Arnalot Palmira, Álvarez-Cubero María Jesús, Cozar José Manuel, Suárez-Novo José Francisco, Castells-Esteve Manel, Fernández-Gonzalo Pablo, De-Paula-Carranza Belén, Ferrer Montse, Guedea Ferrán, Sancho-Pardo Gemma, Craven-Bartle Jordi, Ortiz-Gordillo María José, Cabrera-Roldán Patricia, Rodríguez-Melcón Juan Ignacio, Herrera-Ramos Estefanía, Rodríguez-Gallego Carlos, Lara Pedro |
SRD5A2 gene polymorphisms and the risk of benign prostatic hyperplasia but not prostate cancer. Asian Pacific journal of cancer prevention : APJCP 2015 16 (3): 1033-6. Choubey Vimal Kumar, Sankhwar Satya Narayan, Carlus S Justin, Singh Anand Narayan, Dalela Divakar, Thangaraj Kumarasamy, Rajender Sin |
The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population. Korean journal of urology 2015 Jan 56 (1): 19-30. Choi Se Young, Kim Hae Jong, Cheong Hyun Sub, Myung Soon Ch |
Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients. Turkish journal of medical sciences 2016 46 (3): 626-40. Kachakova Darina, Mitkova Atanaska, Popov Elenko, Beltcheva Olga, Vlahova Alexandrina, Dikov Tihomir, Christova Svetlana, Mitev Vanio, Slavov Chavdar, Kaneva Rad |
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer 2016 May . Price Douglas K, Chau Cindy H, Till Cathee, Goodman Phyllis J, Leach Robin J, Johnson-Pais Teresa L, Hsing Ann W, Hoque Ashraful, Parnes Howard L, Schenk Jeannette M, Tangen Catherine M, Thompson Ian M, Reichardt Juergen K V, Figg William |
Systematic meta-analyses of gene-specific genetic association studies in prostate cancer. Oncotarget 2016 Mar . Hao Qiang, Wei Dong, Zhang Yaoguang, Chen Xin, Yang Fan, Yang Ze, Zhu Xiaoquan, Wang Jian |
The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism. Prostate cancer and prostatic diseases 2016 06 19 (2): 191-6. Shiota M, Fujimoto N, Yokomizo A, Takeuchi A, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Eto |
Re: Single-Nucleotide Polymorphism in the 5-a-Reductase Gene (SRD5A2) is Associated with Increased Prevalence of Metabolic Syndrome in Chemotherapy-Treated Testicular Cancer Survivors. The Journal of urology 2016 12 196 (6): 1677-1678. Richie Jerome |
Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. International journal of clinical and experimental medicine 2015 8 (10): 19232-40. Poniah Prevathe, Mohamed Zahurin, Apalasamy Yamunah Devi, Mohd Zain Shamsul, Kuppusamy Shanggar, Razack Azad |
Single-nucleotide polymorphism in the 5-a-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors. European journal of cancer (Oxford, England : 1990) 2016 Jan 54 104-111. Boer Hink, Westerink Nico-Derk L, Altena Renske, Nuver Janine, Dijck-Brouwer D A Janneke, van Faassen Martijn, Klont Frank, Kema Ido P, Lefrandt Joop D, Zwart Nynke, Boezen H Marike, Smit Andries J, Meijer Coby, Gietema Jourik |
Genotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate Cancer. BioMed research international 2017 2017 3507671. López-Cortés Andrés, Cabrera-Andrade Alejandro, Salazar-Ruales Carolina, Zambrano Ana Karina, Guerrero Santiago, Guevara Patricia, Leone Paola E, Paz-Y-Miño Cés |
Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications. Medicine 2017 May 96 (19): e6791. Fang Cheng, Guo Zhong-Qiang, Chen Xiao-Yan, Liu Tong-Zu, Zeng Xian-Tao, Wang Xing-Hu |
Association of Some Polymorphisms in the VDR Gene, CYP17 Gene and SRD5A2 Gene and Prostate Cancer among Lebanese
Men Asian Pacific journal of cancer prevention : APJCP 2017 01 18 (1): 93-100. El Ezzi Asmahan A, Baker Monika T, Zaidan Wissam R, Hraiki Kalim M, El Saidi Mohammad A, Kuddus Ruhul |
A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy. Cancer biology & therapy 2018 3 19 (8): 669-675. Liu Qiuli, Tong Dali, Liu Gaolei, Yi Yuting, Xu Jing, Yang Xingxia, Wang Linang, Zhang Jun, Ye Jin, Zhang Yao, Yuan Gang, Wang Peng, Chen Rongrong, Guan Yanfang, Yi Xin, Zhang Dianzheng, Jiang J |
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors. Journal of the National Comprehensive Cancer Network : JNCCN 2018 Mar 16 (3): 257-265. Zaid Mohammad Abu, Gathirua-Mwangi Wambui G, Fung Chunkit, Monahan Patrick O, El-Charif Omar, Williams Annalynn M, Feldman Darren R, Hamilton Robert J, Vaughn David J, Beard Clair J, Cook Ryan, Althouse Sandra K, Ardeshir-Rouhani-Fard Shirin, Dinh Paul C, Sesso Howard D, Einhorn Lawrence H, Fossa Sophie D, Travis Lois B, |
Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms. Artificial cells, nanomedicine, and biotechnology 2019 Dec 47 (1): 1101-1112. Wang Le, Wang Hao, Wang Ting, Liu Jinhui, Chen Wei, Wang Yamin, Chen Chao, Zhu Hongli, Dai Pengg |
Steroid 5 alpha-reductase 2 enzyme variants, biomass exposure and tobacco use in Mexican patients with prostate cancer. Oncology letters 2020 9 20 (5): 261. Delgado-Balderas Jesus Rolando, Gallardo-Blanco Hugo Leonid, Yee-De León Juan Felipe, Rivas-Estilla Ana Maria, Soto-García Brenda, Aráiz-Hernández Diana, Garza-Guajardo Raquel, Náñez-Marín Melissa, Hernández-Barajas David, García-Bailón Aldo Missael, Vízcarra-Mata Guillermo, Ocaña-Munguía Marco Alberto, Gómez-Guerra Lauro Salvador, Sánchez-Domínguez Celia Nohe |
Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: a systematic overview. American journal of cancer research 2021 6 11 (5): 1873-1894. Liu Min, Shi Hongzhe, Yan Jiaqing, Zhang Yuan, Ma Yinglin, Le Kaidi, Li Zhongdong, Xing Nianzeng, Li Guoh |
Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study. Cancers 2021 4 13 (8): . Prizment Anna E, McSweeney Sean, Pankratz Nathan, Joshu Corinne E, Hwang Justin H, Platz Elizabeth A, Ryan Charles |
The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer. The pharmacogenomics journal 2021 3 21 (4): 440-445. Shiota Masaki, Akamatsu Shusuke, Narita Shintaro, Sumiyoshi Takayuki, Fujiwara Maki, Uchiumi Takeshi, Ogawa Osamu, Habuchi Tomonori, Eto Masatos |
The CAG-triplet in the androgen receptor gene and single-nucleotide polymorphisms in androgen pathway genes in patients with concomitant bladder and prostate cancer. Urologic oncology 2022 4 40 (5): 198.e1-198.e8. Gakis Georgios, Perner Sven, Stenzl Arnulf, Renninger Mark |
A Phase II Trial of Abiraterone With Dutasteride for Second-Generation Antiandrogen- and Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer. Journal of clinical pharmacology 2022 12 . Shiota Masaki, Inoue Ryo, Tashiro Kojiro, Kobayashi Keita, Horiyama Shizuyo, Kanji Hiromi, Eto Masatoshi, Egawa Shin, Haginaka Jun, Matsuyama Hideya |
Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate. European journal of clinical pharmacology 2022 11 79 (1): 89-98. Takahashi Yoshiko, Narita Shintaro, Shiota Masaki, Miura Masatomo, Kagaya Hideaki, Kashima Soki, Yamamoto Ryohei, Nara Taketoshi, Huang Mingguo, Numakura Kazuyuki, Saito Mitsuru, Eto Masatoshi, Habuchi Tomono |
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 11 169 115890. Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J H Coenen, Andries M Bergman, Stijn L W Koolen, Ronald de Wit, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijss |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: